AAPL   320.48 (+0.80%)
MSFT   181.96 (-0.70%)
FB   228.73 (+1.62%)
GOOGL   1,430.78 (-0.19%)
AMZN   2,470.77 (+1.16%)
NVDA   349.99 (-1.42%)
CGC   16.10 (-7.31%)
BABA   204.59 (-1.35%)
MU   46.81 (-2.30%)
GE   6.69 (+1.67%)
TSLA   881.98 (+5.63%)
AMD   53.49 (-0.58%)
ACB   14.00 (-0.57%)
F   5.80 (+1.58%)
GILD   74.92 (-3.74%)
DIS   118.98 (+1.42%)
NFLX   421.62 (+0.45%)
BAC   24.69 (+2.36%)
BA   150.69 (+3.32%)
AAPL   320.48 (+0.80%)
MSFT   181.96 (-0.70%)
FB   228.73 (+1.62%)
GOOGL   1,430.78 (-0.19%)
AMZN   2,470.77 (+1.16%)
NVDA   349.99 (-1.42%)
CGC   16.10 (-7.31%)
BABA   204.59 (-1.35%)
MU   46.81 (-2.30%)
GE   6.69 (+1.67%)
TSLA   881.98 (+5.63%)
AMD   53.49 (-0.58%)
ACB   14.00 (-0.57%)
F   5.80 (+1.58%)
GILD   74.92 (-3.74%)
DIS   118.98 (+1.42%)
NFLX   421.62 (+0.45%)
BAC   24.69 (+2.36%)
BA   150.69 (+3.32%)
AAPL   320.48 (+0.80%)
MSFT   181.96 (-0.70%)
FB   228.73 (+1.62%)
GOOGL   1,430.78 (-0.19%)
AMZN   2,470.77 (+1.16%)
NVDA   349.99 (-1.42%)
CGC   16.10 (-7.31%)
BABA   204.59 (-1.35%)
MU   46.81 (-2.30%)
GE   6.69 (+1.67%)
TSLA   881.98 (+5.63%)
AMD   53.49 (-0.58%)
ACB   14.00 (-0.57%)
F   5.80 (+1.58%)
GILD   74.92 (-3.74%)
DIS   118.98 (+1.42%)
NFLX   421.62 (+0.45%)
BAC   24.69 (+2.36%)
BA   150.69 (+3.32%)
AAPL   320.48 (+0.80%)
MSFT   181.96 (-0.70%)
FB   228.73 (+1.62%)
GOOGL   1,430.78 (-0.19%)
AMZN   2,470.77 (+1.16%)
NVDA   349.99 (-1.42%)
CGC   16.10 (-7.31%)
BABA   204.59 (-1.35%)
MU   46.81 (-2.30%)
GE   6.69 (+1.67%)
TSLA   881.98 (+5.63%)
AMD   53.49 (-0.58%)
ACB   14.00 (-0.57%)
F   5.80 (+1.58%)
GILD   74.92 (-3.74%)
DIS   118.98 (+1.42%)
NFLX   421.62 (+0.45%)
BAC   24.69 (+2.36%)
BA   150.69 (+3.32%)
Log in

CNSX:PREVPreveceutical Medical Stock Price, Forecast & News

$0.03
0.00 (0.00 %)
(As of 06/1/2020 06:00 AM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range N/A
52-Week Range N/A
Volume923,964 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products. It has research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. The company offers CELLB9 immune system booster, an oral solution containing polarized and potentiated essential minerals extracted from a peptide obtained from Caribbean blue scorpion venom. It also provides medicinal cannabis-based products. The company has a research and option agreement with University of Queensland; and the UniQuest Pty Limited to develop non-addictive analgesics for the treatment of pain. It also has a strategic research and development supply agreement with Aurora Cannabis to produce medical cannabis. PreveCeutical Medical Inc. is based in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone604-416-7777

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PREV News and Ratings via Email

Sign-up to receive the latest news and ratings for PREV and its competitors with MarketBeat's FREE daily newsletter.

Preveceutical Medical (CNSX:PREV) Frequently Asked Questions

Has Preveceutical Medical been receiving favorable news coverage?

News articles about PREV stock have trended somewhat positive on Monday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Preveceutical Medical earned a news sentiment score of 1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutPreveceutical Medical.

Who are some of Preveceutical Medical's key competitors?

What other stocks do shareholders of Preveceutical Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Preveceutical Medical investors own include Aurora Cannabis (ACB), Equinix (EQIX), Bank of Nova Scotia (BNS), Biocept (BIOC), Baidu (BIDU), BlackBerry (BB), Alimentation Couche-Tard (ATD.B), Aphria (APHA), Amarin (AMRN) and Advanced Micro Devices (AMD).

Who are Preveceutical Medical's key executives?

Preveceutical Medical's management team includes the following people:
  • Mr. Stephen Van Deventer, Chairman & CEO (Age 50)
  • Dr. Makarand Jawadekar Ph.D., Chief Science Officer, Pres & Director (Age 68)
  • Ms. Shabira Rajan CPA, CGA, CFO & Controller (Age 63)
  • Ms. Deanna Kress, Director of Corp. Communications & Investor Relations
  • Ms. Alicia Rebman, Marketing Director (Age 42)

What is Preveceutical Medical's stock symbol?

Preveceutical Medical trades on the CNSX under the ticker symbol "PREV."

How do I buy shares of Preveceutical Medical?

Shares of PREV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Preveceutical Medical's stock price today?

One share of PREV stock can currently be purchased for approximately $0.03.

What is Preveceutical Medical's official website?

The official website for Preveceutical Medical is www.preveceutical.com.

How can I contact Preveceutical Medical?

The company can be reached via phone at 604-416-7777.

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.